top of page
  • Writer's pictureKirk Hartley

Mryiad’s Arguments to Enjoin Some Entities Testing for BRCA Genes

Kevin Noonan of Patent Docs has provided an expert, cogent summary of Myriad’s arguments to enjoin some other providers of testing for BRCA genes. However, Kevin is a steadfast advocate for broad patent claims,  so view the analysis with that thought in mind.

#Cancer

0 views0 comments

Recent Posts

See All

The litigation industry is global. The latest example is the start of RoundUp/glyphosate litigation in Australia, as described in this June 3,  2019 article in the Brisbane Times.

bottom of page